![](/img/cover-not-exists.png)
A dose escalation phase 1 study of radiotherapy (RT) in combination with anti-cytotoxic-T-lymphocyte-associated antigen 4 (CTLA-4) monoclonal antibody ipilimumab (Ipi) in patients (pts) with metastatic melanoma
Boutros, C., Mateus, C., Routier, E., Chouaib, S., Libenciuc, C., Reigneau, M., Girault, I., Caramella, C., Hibat, S., Vagner, S., Tao, Y.G., Chaput, N., Adam, J., Soria, J-C., Eggermont, A., Deutsch,Volume:
27
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdw379.12
Date:
October, 2016
File:
PDF, 38 KB
english, 2016